Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung

Donatella Malanga, Marianna Scrima, Carmela De Marco, Fernanda Fabiani, Nicla De Rosa, Silvia De Gisi, Natalia Malara, Rocco Savino, Gaetano Rocco, Gennaro Chiappetta, Renato Franco, Virginia Tirino, Giuseppe Pirozzi, Giuseppe Viglietto

Research output: Contribution to journalArticlepeer-review


Somatic mutation (E17K) that constitutively activates the protein kinase AKT1 has been found in human cancer patients. We determined the role of the E17K mutation of AKT1 in lung cancer, through sequencing of AKT1 exon 4 in 105 resected, clinically annotated non-small cell lung cancer specimens. We detected a missense mutations G→A transition at nucleotide 49 (that results in the E17K substitution) in two squamous cell carcinoma (2/36) but not in adenocarcinoma (0/53). The activity of the endogenous kinase carrying the E17K mutation immunoprecipitated by tumour tissue was significantly higher compared with the wildtype kinase immunoprecipitated by the adjacent normal tissue as determined both by in vitro kinase assay using a consensus peptide as substrate and by in vivo analysis of the phosphorylation status of AKT1 itself (pT308, pS473) or of known downstream substrates such as GSK3 (pS9/S22) and p27 (T198). Immunostaining or immunoblot analysis on membrane-enriched extracts indicated that the enhanced membrane localization exhibited by the endogenous E17K-AKT1 may account for the observed increased activity of mutant E17K kinase in comparison with the wild-type AKT1 from adjacent normal tissue. In conclusion, this is the first report of AKT1 mutation in lung cancer. Our data provide evidence that, although AKT1 mutations are apparently rare in lung cancer (1.9%), the oncogenic properties of E17K-AKT1 may contribute to the development of a fraction of lung carcinoma with squamous histotype (5.5%).

Original languageEnglish
Pages (from-to)665-669
Number of pages5
JournalCell Cycle
Issue number5
Publication statusPublished - Mar 1 2008


  • AKT
  • Lung cancer
  • Mutation
  • Phosphorylation
  • PI3K
  • Squamous carcinoma

ASJC Scopus subject areas

  • Cell Biology
  • Biochemistry
  • Molecular Biology


Dive into the research topics of 'Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung'. Together they form a unique fingerprint.

Cite this